- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Health Care Facilities/Srvcs
- Sub-Industry: Health Care Services
NeoGenomics Inc+ Add to Watchlist
NEO:US3.5800 USD 0.0400 1.10%
As of 16:30:00 ET on 12/18/2013.
Company Profile for NeoGenomics Inc (NEO)
NeoGenomics, Inc. operates a network of clinical laboratories that specialize in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.
Key Executives for NeoGenomics Inc (NEO)
|Douglas M VanoortChairman/CEO||George A CardozaChief Financial Officer|
|Steven A RossChief Information Officer||Maher AlbitarChief Medical Officer|
|Robert P GaspariniChief Scientific Officer||Steven C JonesExec VP:Finance|
|Robert H HorelVP:Sales & Marketing||Edwin F Weidig IIIDir:Finance/Principal Acctg Ofcr|